Molecular Epidemiology of Invasive Aspergillosis: Lessons Learned from an Outbreak Investigation in...
Transcript of Molecular Epidemiology of Invasive Aspergillosis: Lessons Learned from an Outbreak Investigation in...
Molecular Epidemiology of Invasive Aspergillosis: Lessons Learned from an OutbreakInvestigation in an Australian Hematology Unit • Author(s): Sarah E. Kidd, PhD; Li Min Ling, MBBS; Wieland Meyer, PhD; C. Orla Morrissey,PhD; Sharon C. A. Chen, PhD; Monica A. Slavin, MDSource: Infection Control and Hospital Epidemiology, Vol. 30, No. 12 (December 2009), pp.1223-1226Published by: The University of Chicago Press on behalf of The Society for Healthcare Epidemiologyof AmericaStable URL: http://www.jstor.org/stable/10.1086/648452 .
Accessed: 15/05/2014 16:07
Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at .http://www.jstor.org/page/info/about/policies/terms.jsp
.JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range ofcontent in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new formsof scholarship. For more information about JSTOR, please contact [email protected].
.
The University of Chicago Press and The Society for Healthcare Epidemiology of America are collaboratingwith JSTOR to digitize, preserve and extend access to Infection Control and Hospital Epidemiology.
http://www.jstor.org
This content downloaded from 193.105.154.110 on Thu, 15 May 2014 16:07:22 PMAll use subject to JSTOR Terms and Conditions
infection control and hospital epidemiology december 2009, vol. 30, no. 12
c o n c i s e c o m m u n i c a t i o n
Molecular Epidemiology of InvasiveAspergillosis: Lessons Learnedfrom an Outbreak Investigationin an Australian Hematology Unit
Sarah E. Kidd, PhD; Li Min Ling, MBBS;Wieland Meyer, PhD; C. Orla Morrissey, PhD;Sharon C. A. Chen, PhD; Monica A. Slavin, MD
Suspected nosocomial Aspergillus fumigatus infections in an Austra-lian hematology unit were investigated by molecular typing of clin-ical and environmental isolates using polymerase chain reaction fin-gerprinting, CSP typing, and multilocus microsatellite typing. Onlymultilocus microsatellite typing revealed that all isolates were ge-netically distinct. The selection of an appropriate typing method isessential for effective outbreak investigations.
Infect Control Hosp Epidemiol 2009; 30:1223-1226
Invasive aspergillosis (IA) in immunocompromised hosts isassociated with significant morbidity and mortality. Clustersof IA are common in hospitals, and molecular typing tech-nologies are needed to rapidly and accurately track infection.Because typing methods for Aspergillus fumigatus differ intheir ability to discriminate between strains,1 it is crucial toselect appropriate method(s). Here, we describe our inves-tigation of a suspected outbreak of IA at the Peter MacCallumCancer Centre (PMCC; Melbourne, Victoria, Australia) withuse of 3 typing techniques. We review the strengths and weak-nesses of frequently used typing techniques and make rec-ommendations about their use in investigations of outbreaksof A. fumigatus infection.
ia cases
From March 19 through April 27, 2006, 3 inpatients receiveda diagnosis of proven pulmonary IA after their admission tothe PMCC up to 3 months earlier. Patients A and B wereadmitted for total body irradiation as part of the stem celltransplantation conditioning regimen, and patient C had re-ceived chemotherapy and mediastinal irradiation for relapsedlymphoma. A. fumigatus was cultured from lung tissue orsputum specimens. All patients died from IA-related respi-ratory failure. Common areas attended by these patients in-cluded the intensive care unit (ICU) and radiotherapy unit.
methods
Air sampling was undertaken in and near the ICU and ra-diotherapy units 2 weeks after diagnosis of the third IA case.
A MAS-100 air sampler (Merck) was used to collect 11 sam-ples of 1000 L per 10 minutes. Thirty swab samples werecollected from surfaces, such as window sills, curtain rails,televisions, computer monitors, wall tiles, and air vents, withuse of sterile transport swabs. Samples were sent to the De-partment of Microbiology, Box Hill Hospital (Melbourne),for further processing and morphological identification of A.fumigatus isolates.
Molecular typing of isolates was initially conducted usingpolymerase chain reaction (PCR) fingerprinting,2 by whichgenotypes were assigned according to observed differences inbanding patterns. CSP typing3,4 and multilocus microsatellitetyping (MLMT) using the STRAf protocol5 were later appliedto these isolates as part of a different study. CSP types wereassigned according to differences in tandem repeat sequencesof the CSP locus and to point mutations in the flankingregions, in line with a recently proposed CSP typing nomen-clature.4 MLMT profiles were assigned according to the num-ber of repeat units detected in each of 9 A. fumigatus–specificmicrosatellite loci.5 For 1 environmental isolate that was un-typeable by both CSP typing and MLMT, the internal tran-scribed spacer ribosomal DNA regions were sequenced usinguniversal fungal primers,6 and these sequences were comparedwith sequences submitted to the National Center for Bio-technology Information database (http://www.ncbi.nlm.nih.gov/) to determine the species.
results
Three A. fumigatus isolates recovered from the patients, 5from air samples, and 3 from surface swab samples wereavailable for study. All environmental isolates, with the ex-ception of one from an air sample, were obtained in the ICU.
PCR fingerprinting revealed identical banding patterns forthe isolates from patients A and B and for 4 environmentalisolates; the isolate from patient C had a unique bandingpattern (Table 1). CSP typing, however, indicated that patientsA and B had genetically distinct strains, and the isolates frompatients B and C shared the same CSP type. The isolate frompatient A shared a CSP type with 3 environmental isolates,and the isolates from patients B and C isolates shared a CSPtype with 1 environmental isolate. MLMT distinguished allclinical and environmental isolates as genetically distinctstrains (Table 1).
CSP typing and MLMT failed to provide a result for en-vironmental isolate 06.587, although PCR fingerprintingyielded a unique banding pattern for this isolate. Internaltranscribed spacer sequencing indicated that 06.587 had beenmisidentified and was actually Aspergillus terreus; therefore,it was irrelevant to this outbreak investigation.
This content downloaded from 193.105.154.110 on Thu, 15 May 2014 16:07:22 PMAll use subject to JSTOR Terms and Conditions
ta
ble
1.M
olec
ula
rTy
pin
gR
esu
lts
for
Clin
ical
and
En
viro
nm
enta
lIs
olat
es
Isol
ate
sou
rce
Dia
gnos
isIs
olat
esi
te
Isol
ate
no.
Spec
ies
PC
R
fin
gerp
rin
t
type
CSP
type
MLM
Tpr
ofile
a
STR
Af2
AST
RA
f2B
STR
Af2
CST
RA
f3A
STR
Af3
BST
RA
f3C
STR
Af4
AST
RA
f4B
STR
Af4
C
Pat
ien
t
AP
ulm
onar
yIA
,SC
Tco
ndi
tion
ing
Lun
gti
ssu
e06
.262
Asp
ergi
llus
fum
igat
us1
t04A
1923
1450
3019
179
5
BP
ulm
onar
yIA
,SC
Tco
ndi
tion
ing
Lun
gti
ssu
e06
.263
A.
fum
igat
us1
t01
1922
1840
1120
12.3
97
CP
rove
npu
lmon
ary
IA,
rela
psed
Bce
ll
lym
phom
a
Spu
tum
06.3
57A
.fu
mig
atus
3t0
120
1716
4211
2615
118
En
viro
nm
ent
Isol
ate
1…
Surf
ace
swab
06.5
83A
.fu
mig
atus
5t0
317
1213
159
188
85
Isol
ate
2…
Surf
ace
swab
06.5
84A
.fu
mig
atus
1t0
119
2226
3241
188
98
Isol
ate
3…
Surf
ace
swab
06.5
85A
.fu
mig
atus
1t0
311
1214
3615
1326
95
Isol
ate
4…
Air
sam
ple
06.5
77A
.fu
mig
atus
4t0
213
2011
319
108
1020
Isol
ate
5…
Air
sam
ple
06.5
86A
.fu
mig
atus
1t0
4A18
1211
3314
128
85
Isol
ate
6…
Air
sam
ple
06.5
88A
.fu
mig
atus
1t0
4A19
2218
5011
2112
.39
5
Isol
ate
7…
Air
sam
ple
06.5
89A
.fu
mig
atus
2t0
4A18
2520
2911
717
.310
8
Isol
ate
8…
Air
sam
ple
06.5
87A
sper
gillu
ste
rreu
sb6
……
……
……
……
……
no
te
.IA
,in
vasi
veas
perg
illos
is;
MLM
T,m
ult
ilocu
sm
icro
sate
llite
typi
ng;
PC
R,
poly
mer
ase
chai
nre
acti
on;
SCT,
stem
cell
tran
spla
nt.
aM
LMT
profi
les
repr
esen
tth
en
um
ber
ofre
peat
un
its
atea
chm
icro
sate
llite
locu
s.b
Spec
ies
was
dete
rmin
edby
sequ
enci
ng
ofth
ein
tern
altr
ansc
ribe
dsp
acer
regi
ons
ofth
eri
boso
mal
DN
Aan
dco
mpa
riso
nw
ith
hom
olog
ous
sequ
ence
sst
ored
inth
eN
atio
nal
Cen
ter
forB
iote
chn
olog
yIn
form
atio
nda
taba
se.
This content downloaded from 193.105.154.110 on Thu, 15 May 2014 16:07:22 PMAll use subject to JSTOR Terms and Conditions
molecular typing of an outbreak of a. fumigatus infection 1225
table 2. Strengths and Weaknesses of Commonly Used Techniques for Aspergillus fumigatus Strain Typing
TechniqueDiscriminatory
power ReproducibilityEase of
performance Ease of interpretationA. fumigatus–
specific protocolAmenability to
data sharing Reference(s)
Probe-based fingerprintingAfut1-RFLP Moderate Moderate Good Difficult, subjective Yes Poor 1
PCR-based fingerprintingPCR fingerprinting Moderate Poor Good Moderate, subjective No Poor 2
RAPD Moderate Poor Good Difficult, subjective No Poor 1, 2, 7
AFLP High Moderate Moderate Difficult, subjective No Poor 1, 7
Specific locus typingCSP typing Moderate Good Good Easy, objective Yes Good 3, 4
MLST Poora Good Moderate Easy, objective Yes Good 1, 7, 8
MLMT High Good Good Easy, objective Yes Good 1, 5, 9, 10
note. Adapted from de Valk et al.1 AFLP, amplified fragment length polymorphism; MLMT, multilocus microsatellite typing; MLST, multilocussequence typing; PCR, polymerase chain reaction; RAPD, random amplification of polymorphic DNA; RFLP, restriction fragment lengthpolymorphism.a MLST has been demonstrated to be highly discriminatory in many fungal species, but the only scheme developed for A. fumigatus to date hasvery poor discriminatory power.8
discussion
Nosocomial IA is associated with significant morbidity amongpatients, and this has important implications for infectioncontrol practice. In this study, the initial results showed thatisolates from patients A and B and several environmentalsamples shared identical PCR fingerprint profiles, suggestingthat nosocomial infection was likely. In response, the ICUwas closed and thoroughly cleaned, faulty structures (ie, airvents, cracked ceiling tiles, and light fittings) were replaced,and more-stringent infection control measures were imple-mented. There have been no IA cases related to the ICU atPMCC since the outbreak.
In contrast to the initial findings, the subsequent analysisusing MLMT indicated no evidence for common sources ofinfection. However, despite all isolates eventually being foundto be genetically distinct, it is possible that the ICU was thesource of one or more infections and that environmentalsampling was insufficient to detect all strains in the vicinity.Up to 3 months had elapsed between the patients’ admissionto PMCC and the environmental sampling. Therefore, it isalso possible that the collected environmental isolates werenot representative of those that were in the patients’ sur-roundings at the time of acquisition, if the infections werehospital acquired. With the expanding spectrum of moleculartechniques in diagnostics and infection control, it is impor-tant for clinicians to understand their use and clinical rele-vance. This is particularly the case for A. fumigatus, for whichthere is no gold standard typing technique. This study illus-trates the significant variation in discriminatory power be-tween techniques, and although not directly addressed here,techniques also differ in their reproducibility, ease of perfor-mance and interpretation, and amenability to data set com-parison. The strengths and weaknesses of different techniquesmust be considered before their implementation in an infectioncontrol program. Table 2 summarizes some of the moleculartyping techniques commonly applied to A. fumigatus.
Molecular typing techniques may be broadly classified as
probe-based fingerprinting, PCR-based fingerprinting, or spe-cific locus typing methods. Probe- or PCR-based fingerprintingtechniques are simple to implement and are relatively cost andlabor efficient.1,2,7 The primers and enzymes used in these meth-ods are often not species specific and can be applied to anyfungal species, without developing and validating new proto-cols. However, the discriminatory power of these techniquesvaries between species. In our experience, PCR fingerprinting,which has successfully been used to distinguish strains withinmany fungal species,2 did not distinguish between all strainsof A. fumigatus in this investigation, leading initially to thelikely erroneous conclusion that this outbreak was nosocomial.Furthermore, because the protocols are not species specific, itis not possible to discern that a culture has been misidentifiedusing fingerprinting methods alone. Subjective interpretationof bands of varying intensity may also lead to problems ofreproducibility.
Multilocus sequence typing, the preferred technique fordistinguishing strains of many fungal species because of itssensitivity, reproducibility, and amenability to data sharing,1,7
was not applied to isolates in the present study, because at-tempts to define a useful multilocus sequence typing schemefor A. fumigatus have thus far failed to achieve sufficientdiscriminatory power.8 The single-locus CSP typing methodshares many of the advantages of multilocus sequence typingand has been recommended for use as a first-line typingmethod for A. fumigatus isolates.3 However, it did not dis-tinguish between all strains in the present study.
The recently developed MLMT STRAf protocol is rapidlybecoming the preferred technique for molecular typing of A.fumigatus because of its extremely high discriminatory powerand reproducibility.1,5,9 With the increasing availability of com-mercial genotyping services, MLMT can be conducted withoutthe need for specialized laboratory equipment and at relativelylow cost. Furthermore, with use of allelic ladders, this methodcan be standardized for interlaboratory or longitudinal datacomparisons (Table 2).10 In light of ours and others’ experience
This content downloaded from 193.105.154.110 on Thu, 15 May 2014 16:07:22 PMAll use subject to JSTOR Terms and Conditions
1226 infection control and hospital epidemiology december 2009, vol. 30, no. 12
with this method for genotyping A. fumigatus case clusters,9
we recommend its use for investigations of suspected outbreaksof A. fumigatus infection wherever resources permit.
The application of any molecular typing method in theclinical setting requires knowledge of the intrinsic propertiesof the organism and of the resources available. In addition,if additional outbreaks occur, consideration should be givento the capacity of any technique for long-term data collectionand comparison.
acknowledgments
We thank Susan Harper and Steve Burden, for their assistance with envi-ronmental sampling; the Department of Microbiology, Box Hill Hospital,Melbourne, for identification of clinical and environmental isolates; KrystynaMaszewska, for polymerase chain reaction fingerprinting of isolates; andKarin Thursky, for reviewing the manuscript.
Potential conflicts of interest. All authors report no conflicts of interestrelevant to this article.
From the Department of Medicine, Monash University (S.E.K., C.O.M.),Infectious Diseases Unit, Alfred Hospital (S.E.K., L.M.L., C.O.M., M.A.S.),MacFarlane Burnet Institute (S.E.K., C.O.M.), Infectious Diseases Unit, PeterMacCallum Cancer Centre (L.M.L., M.A.S.), and Centre for Clinical ResearchExcellence in Infectious Diseases, Victorian Infectious Diseases Service(M.A.S.), Melbourne, Victoria, and Centre for Infectious Diseases and Mi-crobiology, Westmead Hospital (W.M., S.C.A.C.), and Department of Med-icine, University of Sydney Western Clinical School, Westmead MillenniumInstitute (W.M., S.C.A.C.), Sydney, New South Wales, Australia; and Infec-tious Diseases Department, Tan Tock Seng Hospital, Singapore (L.M.L.)
Address reprint requests to Assoc. Prof. Monica Slavin, Locked Bag 1,A’Beckett Street, Melbourne, VIC, 8006, Australia ([email protected]).
Received May 20, 2009; accepted July 22, 2009; electronically published Oc-tober 22, 2009.
� 2009 by The Society for Healthcare Epidemiology of America. All rightsreserved. 0899-823X/2009/3012-0014$15.00. DOI: 10.1086/648452
references
1. de Valk HA, Klaassen CH, Meis JF. Molecular typing of Aspergillus species.Mycoses 2008; 51:463–476.
2. Meyer W, Marszewska K, Amirmostofian M, et al. Molecular typing ofglobal isolates of Cryptococcus neoformans var. neoformans by polymerasechain reaction fingerprinting and randomly amplified polymorphic DNA—a pilot study to standardize techniques on which to base a detailed epi-demiological survey. Electrophoresis 1999; 20:1790–1799.
3. Balajee SA, Tay ST, Lasker BA, Hurst SF, Rooney AP. Characterizationof a novel gene for strain typing reveals substructuring of Aspergillusfumigatus across North America. Eukaryot Cell 2007; 6:1392–1399.
4. Klaassen CH, de Valk HA, Balajee SA, Meis JF. Utility of CSP typing tosub-type clinical Aspergillus fumigatus isolates and proposal for a newCSP type nomenclature. J Microbiol Methods 2009; 77:292–296.
5. de Valk HA, Meis JF, Curfs IM, Muehlethaler K, Mouton JW, KlaassenCH. Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol2005; 43:4112–4120.
6. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencingof fungal ribosomal RNA genes for phylogenetics. In: Innis MA, GelfandDH, Sninsky JJ, White TJ, eds. PCR protocols—a guide to methods andapplications. San Diego, CA: Academic Press; 1990:315–322
7. Singh A, Goering RV, Simjee S, Foley SL, Zervos MJ. Application of mo-lecular techniques to the study of hospital infection. Clin Microbiol Rev2006; 19:512–530.
8. Bain JM, Tavanti A, Davidson AD, et al. Multilocus sequence typing ofthe pathogenic fungus Aspergillus fumigatus. J Clin Microbiol 2007; 45:1469–1477.
9. Balajee SA, de Valk HA, Lasker BA, Meis JF, Klaassen CH. Utility of amicrosatellite assay for identifying clonally related outbreak isolates ofAspergillus fumigatus. J Microbiol Methods 2008; 73:252–256.
10. de Valk HA, Meis JF, Bretagne S, et al. Interlaboratory reproducibilityof a microsatellite-based typing assay for Aspergillus fumigatus throughthe use of allelic ladders: proof of concept. Clin Microbiol Infect 2009; 15:180–187.
This content downloaded from 193.105.154.110 on Thu, 15 May 2014 16:07:22 PMAll use subject to JSTOR Terms and Conditions